SCHEMBL196301

SCHEMBL196301

Cc1ccc2oc(-c3ccccc3O)nc2c1

nearest known ligand 0.63

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 10/20 0.63
RAB9A P51151 9/20 0.63
NPC1 O15118 8/20 0.63
SMN1; SMN2 Q16637 6/20 0.63
HPGD P15428 6/20 0.63
CASP3 P42574 4/20 0.63
SENP7 Q9BQF6 4/20 0.63
SENP6 Q9GZR1 4/20 0.63
SENP8 Q96LD8 3/20 0.63
POLB P06746 2/20 0.63
ALDH1A1 P00352 7/20 0.58
HSD17B10 Q99714 5/20 0.58
TP53 P04637 4/20 0.58
MAPT P10636 6/20 0.57
ESR1 P03372 2/20 0.57
ESR2 Q92731 2/20 0.57
TOP2A P11388 1/20 0.57
TSHR P16473 1/20 0.57
GAA P10253 1/20 0.56
MEN1 O00255 1/20 0.54

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1550678 1.00 KDM4E (0.63) KDM4ERAB9ANPC1SMN1; SMN2HPGD
SCHEMBL1549478 0.98 KDM4E (0.61) KDM4ERAB9ANPC1SMN1; SMN2HPGD
SCHEMBL802768 0.88 HSD17B10 (0.60) KDM4ERAB9ANPC1SMN1; SMN2HPGD
SCHEMBL13866524 0.84 ESR1 (0.60) KDM4ERAB9ANPC1SMN1; SMN2HPGD
SCHEMBL14148310 0.84 RAB9A (0.73) KDM4ERAB9ANPC1SMN1; SMN2HPGD
SCHEMBL13866517 0.84 TOP2A (0.62) KDM4ERAB9ANPC1SMN1; SMN2HPGD
SCHEMBL802592 0.83 MAPT (0.55) KDM4ERAB9ANPC1SMN1; SMN2HPGD
SCHEMBL7053445 0.83 KDM6B (0.61) KDM4ERAB9ANPC1SMN1; SMN2HPGD
SCHEMBL2243598 0.83 MAPT (0.71) KDM4ERAB9ANPC1SMN1; SMN2HPGD
SCHEMBL13620844 0.83 KDM4E (0.69) KDM4ERAB9ANPC1SMN1; SMN2HPGD

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 23 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9221770-B2 Compounds having electron transport properties, their preparation and use MERCK PATENT GMBH (DE) 2015-12-29 US claimed
JP-2012500235-A 2012-01-05 JP claimed
US-20110108819-A1 COMPOUNDS HAVING ELECTRON TRANSPORT PROPERTIES, THEIR PREPARATION AND USE MERCK PATENT GMBH (DE) 2011-05-12 US claimed
EP-2313383-A1 COMPOUNDS HAVING ELECTRON TRANSPORT PROPERTIES, THEIR PREPARATION AND USE Merck Patent GmbH (DE) 2011-04-27 EP claimed
WO-2010020352-A1 COMPOUNDS HAVING ELECTRON TRANSPORT PROPERTIES, THEIR PREPARATION AND USE MERCK PATENT GMBH (DE) 2010-02-25 WO claimed
US-9601704-B2 Organic light-emitting device and display apparatus CANON KABUSHIKI KAISHA (JP) 2017-03-21 US disclosed
US-9466804-B2 Organic light-emitting element CANON KABUSHIKI KAISHA (JP) 2016-10-11 US disclosed
US-9221770-B2 Compounds having electron transport properties, their preparation and use MERCK PATENT GMBH (DE) 2015-12-29 US disclosed
US-9221770-B2 Compounds having electron transport properties, their preparation and use MERCK PATENT GMBH (DE) 2015-12-29 US disclosed
US-9221770-B2 Compounds having electron transport properties, their preparation and use MERCK PATENT GMBH (DE) 2015-12-29 US disclosed
US-20150364703-A1 ORGANIC LIGHT-EMITTING DEVICE AND DISPLAY APPARATUS CANON KABUSHIKI KAISHA (JP) 2015-12-17 US disclosed
US-20150357587-A1 ORGANIC LIGHT-EMITTING ELEMENT SAMSUNG ELECTRONICS CO., LTD. (KR) 2015-12-10 US disclosed
US-20110108819-A1 COMPOUNDS HAVING ELECTRON TRANSPORT PROPERTIES, THEIR PREPARATION AND USE MERCK PATENT GMBH (DE) 2011-05-12 US disclosed
US-20110108819-A1 COMPOUNDS HAVING ELECTRON TRANSPORT PROPERTIES, THEIR PREPARATION AND USE MERCK PATENT GMBH (DE) 2011-05-12 US disclosed
US-20110108819-A1 COMPOUNDS HAVING ELECTRON TRANSPORT PROPERTIES, THEIR PREPARATION AND USE MERCK PATENT GMBH (DE) 2011-05-12 US disclosed
EP-2313383-A1 COMPOUNDS HAVING ELECTRON TRANSPORT PROPERTIES, THEIR PREPARATION AND USE Merck Patent GmbH (DE) 2011-04-27 EP disclosed
WO-2010085664-A1 SOLAR CELL MODULES WITH POLY(VINYL BUTYRAL) ENCAPSULANT COMPRISING UNSATURATED HETEROCYCLIC COMPOUND E. I. DU PONT DE NEMOURS AND COMPANY (US) 2010-07-29 WO disclosed
US-20100180947-A1 SOLAR CELL MODULES WITH POLY(VINYL BUTYRAL) ENCAPSULANT COMPRISING UNSATURATED HETEROCYCLIC COMPOUND E. I. DU PONT DE NEMOURS AND COMPANY (US) 2010-07-22 US disclosed
WO-2010020352-A1 COMPOUNDS HAVING ELECTRON TRANSPORT PROPERTIES, THEIR PREPARATION AND USE MERCK PATENT GMBH (DE) 2010-02-25 WO disclosed
WO-2010020352-A1 COMPOUNDS HAVING ELECTRON TRANSPORT PROPERTIES, THEIR PREPARATION AND USE MERCK PATENT GMBH (DE) 2010-02-25 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20110108819-A1 COMPOUNDS HAVING ELECTRON TRANSPORT PROPERTIES, THEIR PREPARATION AND USE SLC25A21, SLCO4C1, SLCO1B3 KDM4E 4607/4885RAB9A 1290/4885NPC1 53/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.